Inactivation of DL1 in PDGFβ+ BECs or CD11c+ DCs does not perturb MZ B cell development. (A) Spleen sections of control (DL1lox/lox) and induced DL1PDGFβiCreERT mice were stained for Collagen IV and GFP. Collagen IV stains basement membranes, most notably around blood vessels and in the marginal sinus. GFP is expressed bicistronically by the PDGFβ-promoter transgene construct. The dashed boxes are represented as a higher magnification on the right or below. B, B cell follicle; T, T cell zone; CA, central arteriole; MS, marginal sinus. Arrows indicate BECs and arrowheads the marginal sinus. (B) DL1 deletion PCR on sorted CD45−Ter119−CD31+ endothelial cells from spleens of control and tamoxifen-injected DL1Δ/ΔPDGFβ mice. (C) Representative flow cytometry profile of MZ B cells (gated as CD21hiCD23int), pregated on B220+IgMhi cells, in spleens of control and tamoxifen-injected DL1Δ/ΔPDGFβ mice. (D) Bar diagrams show relative (left) and absolute cell number (right) of MZ B cells (MZB) in spleens of control and TAM-injected DL1Δ/ΔPDGFβ mice (means ± SD of 4–5 animals per group). One of two representative experiments is shown. (E) Bar diagrams show relative (left) and absolute number (right) of splenic MZ B cells of control and DL1Δ/ΔCD11c mice (means ± SD of 4–5 animals per group).